Yung-Ping Yeh

Yung-Ping Yeh is a declared insider of Vyant Bio, Inc., with filings sourced from SEC (Form 4). In total, 5 filings cover trades dated from 30 March 2021 to 30 March 2022.

Every open-market trade on record is a purchase: 3 purchases worth €5,842, and no sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 1 share grant.

The median purchase comes to €2,242. Clusters matter here: 3 out of 3 purchases overlapped with buying by a colleague within 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.

The newest entry dates from 1 April 2022: a share grant, in Vyant Bio, Inc. The last purchase on record was published on 23 November 2021, which is 1,790 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.